DIETHYLPROPION HYDROCHLORIDE

N/A

Manufactured by Chartwell RX, LLC.

370 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DIETHYLPROPION HYDROCHLORIDE

DIETHYLPROPION HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chartwell RX, LLC.. The most commonly reported adverse reactions for DIETHYLPROPION HYDROCHLORIDE include CHRONIC KIDNEY DISEASE, DRUG INEFFECTIVE, PAIN, RENAL FAILURE, ANXIETY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DIETHYLPROPION HYDROCHLORIDE.

Top Adverse Reactions

CHRONIC KIDNEY DISEASE15 reports
DRUG INEFFECTIVE13 reports
PAIN13 reports
RENAL FAILURE11 reports
ANXIETY10 reports
DIZZINESS7 reports
WEIGHT DECREASED7 reports
ACUTE KIDNEY INJURY6 reports
DEPRESSION6 reports
DYSPNOEA6 reports
EMOTIONAL DISTRESS6 reports
FATIGUE6 reports
INJURY6 reports
NAUSEA6 reports
SMALL FOR DATES BABY6 reports
VOMITING6 reports
ALOPECIA5 reports
CHRONIC KIDNEY DISEASE MINERAL AND BONE DISORDER5 reports
COUGH5 reports
DIARRHOEA5 reports
END STAGE RENAL DISEASE5 reports
FOETAL EXPOSURE DURING PREGNANCY5 reports
HYPOAESTHESIA5 reports
ASTHMA4 reports
CARDIAC DISORDER4 reports
GENERAL PHYSICAL HEALTH DETERIORATION4 reports
MYOCARDIAL INFARCTION4 reports
NASOPHARYNGITIS4 reports
PARAESTHESIA4 reports
SINUSITIS4 reports
UPPER RESPIRATORY TRACT INFECTION4 reports
URINARY TRACT INFECTION4 reports
ABDOMINAL PAIN UPPER3 reports
ANAEMIA3 reports
ARTHRALGIA3 reports
ATRIAL FIBRILLATION3 reports
BACK PAIN3 reports
CARDIAC FAILURE CONGESTIVE3 reports
CHEST PAIN3 reports
CHOLECYSTITIS CHRONIC3 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE3 reports
COVID 193 reports
DEATH3 reports
DECREASED APPETITE3 reports
DEHYDRATION3 reports
DUODENITIS3 reports
ERYTHEMA3 reports
FALL3 reports
GASTROOESOPHAGEAL REFLUX DISEASE3 reports
HEADACHE3 reports
HYPERHIDROSIS3 reports
IMPAIRED QUALITY OF LIFE3 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION3 reports
INFLUENZA3 reports
INJECTION SITE PAIN3 reports
INJECTION SITE PRURITUS3 reports
MALAISE3 reports
MUSCLE SPASMS3 reports
NASAL CONGESTION3 reports
PNEUMONIA3 reports
PRODUCT PHYSICAL ISSUE3 reports
PULMONARY EMBOLISM3 reports
RHINORRHOEA3 reports
SLEEP APNOEA SYNDROME3 reports
SOMNOLENCE3 reports
ABDOMINAL DISCOMFORT2 reports
ANHEDONIA2 reports
ASTHENIA2 reports
BLOOD PRESSURE INCREASED2 reports
BONE DENSITY DECREASED2 reports
BRONCHITIS2 reports
CARPAL TUNNEL SYNDROME2 reports
CHOLELITHIASIS2 reports
CONSTIPATION2 reports
CYSTITIS2 reports
DRUG INTERACTION2 reports
DRY EYE2 reports
DRY SKIN2 reports
DYSKINESIA2 reports
EAR INFECTION2 reports
GALLBLADDER DISORDER2 reports
GALLBLADDER INJURY2 reports
HAEMOGLOBIN DECREASED2 reports
HYPERSENSITIVITY2 reports
IMPAIRED GASTRIC EMPTYING2 reports
INCORRECT DOSE ADMINISTERED2 reports
INFECTION2 reports
INFUSION RELATED REACTION2 reports
INJECTION SITE SWELLING2 reports
INSOMNIA2 reports
INTENTIONAL DOSE OMISSION2 reports
MEMORY IMPAIRMENT2 reports
NEPHROGENIC ANAEMIA2 reports
NEPHROPATHY2 reports
NEUROPATHY PERIPHERAL2 reports
OFF LABEL USE2 reports
OVERDOSE2 reports
PAIN IN EXTREMITY2 reports
PANCREATITIS2 reports
PHARYNGITIS STREPTOCOCCAL2 reports

Report Outcomes

Out of 124 classified reports for DIETHYLPROPION HYDROCHLORIDE:

Serious 66.9%Non-Serious 33.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female92 (79.3%)
Male24 (20.7%)

Reports by Age

Age 466 reports
Age 15 reports
Age 385 reports
Age 564 reports
Age 423 reports
Age 553 reports
Age 573 reports
Age 703 reports
Age 312 reports
Age 322 reports
Age 342 reports
Age 372 reports
Age 482 reports
Age 492 reports
Age 522 reports
Age 542 reports
Age 612 reports
Age 632 reports
Age 832 reports
Age 241 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DIETHYLPROPION HYDROCHLORIDE?

This profile reflects 370 FDA FAERS reports that mention DIETHYLPROPION HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DIETHYLPROPION HYDROCHLORIDE?

Frequently reported terms in FAERS include CHRONIC KIDNEY DISEASE, DRUG INEFFECTIVE, PAIN, RENAL FAILURE, ANXIETY, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DIETHYLPROPION HYDROCHLORIDE?

Labeling and FAERS entries often list Chartwell RX, LLC. in connection with DIETHYLPROPION HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.